Inhibition of Norepinephrine-Induced Cardiac Hypertrophy in S100beta Transgenic Mice.

Journal of Clinical Investigation- United States

doi 10.1172/jci3077

Full Text

Abstract

Available in

Categories

Date

October 15, 1998

Authors

Publisher

American Society for Clinical Investigation

Related search

Cardiac-Specific Overexpression of Diacylglycerol Kinase Prevents Gq Protein-Coupled Receptor Agonist-Induced Cardiac Hypertrophy in Transgenic Mice

Cardiovascular Medicine

English

Inhibition of Carnitine Palymitoyltransferase1b Induces Cardiac Hypertrophy and Mortality in Mice

Diabetes, Obesity and Metabolism

Internal Medicine

English

Regression of Isoproterenol-Induced Cardiac Hypertrophy by Na+/H+ Exchanger Inhibition

Internal Medicine

English

Salt-Sensitive Hypertension and Cardiac Hypertrophy in Transgenic Mice Expressing a Corin Variant Identified in Blacks

Internal Medicine

English

Targeted Inhibition of Calcineurin in Pressure-Overload Cardiac Hypertrophy

Journal of Biological Chemistry

Molecular Biology

English

Cardiac Tumors and Dysrhythmias in Transgenic Mice

Toxicologic Pathology

Forensic Medicine

Molecular Biology

English

Pivotal Role of a Gp91phox-Containing NADPH Oxidase in Angiotensin II-Induced Cardiac Hypertrophy in Mice

Cardiovascular Medicine

English

Histone Methyltransferase SET1 Mediates Angiotensin II-Induced Endothelin-1 Transcription and Cardiac Hypertrophy in Mice

Arteriosclerosis, Thrombosis, and Vascular Biology

Cardiovascular Medicine

English

Calcineurin Inhibition and Cardiac Hypertrophy: A Matter of Balance

Proceedings of the National Academy of Sciences of the United States of America

Multidisciplinary

English